Skip to main content
Back to news
Cryptovia Decrypt

CME to Sue CFTC Over Bitcoin Perpetual Futures Approval, CEO Says

Share

CME CEO Terry Duffy announced the exchange will sue the CFTC over its approval of Bitcoin perpetual futures, arguing they are swaps under Dodd-Frank.

CME to Sue CFTC Over Bitcoin Perpetual Futures Approval, CEO Says

CME Group CEO Terry Duffy said the exchange will file a lawsuit Thursday against the Commodity Futures Trading Commission (CFTC) over its approval of Bitcoin perpetual futures, arguing that the products are actually swaps under the Dodd-Frank Act and fall outside the CFTC's authority.

Duffy, who is set to leave CME later this year, made the announcement during a congressional hearing, stating that perpetual futures—which have no expiration date—function like swaps and should be regulated as such. The lawsuit challenges the CFTC's classification of these contracts as futures, which would allow them to trade on designated contract markets. CME argues that the CFTC overstepped its regulatory mandate by approving a product that does not meet the legal definition of a futures contract.

The legal battle could have significant implications for crypto derivatives markets. If CME prevails, it may force exchanges offering Bitcoin perpetuals to restructure their products or face regulatory uncertainty. For crypto traders, the outcome could affect liquidity and pricing in the perpetual futures market, a key venue for leveraged speculation. NowPrice's crypto page provides real-time pricing for Bitcoin and related derivatives to help traders monitor market reactions.

Market participants will watch for further developments in the case, including the CFTC's response and any potential impact on other crypto derivatives approvals. The lawsuit also raises broader questions about the regulatory framework for digital asset products, with possible implications for future rulemaking under the Commodity Exchange Act.

Read the original article on Decrypt
Editorial summary by NowPrice. Read the original article at the source for full reporting.